News
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Pfizer and Eli Lilly reporting significant - and opposing - news in the GLP-1 industry Lexaria's technology could enhance performance and lower side effects KELOWNA, BC / ACCESS Newswire / April 23, ...
GLP-1 pills can be a promising option for people ... including Novo Nordisk and Roche Holdings, Viking Therapeutics, and Structured Therapeutics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results